Safety and Efficacy of BKM120 in Relapsed and Refractory NHL

Mise à jour : Il y a 4 ans
Référence : NCT01693614

Femme et Homme

Extrait

This is a phase II study evaluating the safety, tolerability and efficacy of BKM120 in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL) or follicular lymphoma (FL).


Critère d'inclusion

  • Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma


Liens